Related Experiment Videos
AMP-activated protein kinase: a potential target for ginsenosides?
Mi Song Jung1, Sung Hyun Chung
1Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 130-701, Korea.
Archives of Pharmacal Research
|August 4, 2011
Summary
Ginsenoside Rb2 from Panax ginseng inhibits glucose production in liver cells by activating AMP-activated protein kinase (AMPK). This finding identifies Rb2 as a novel antidiabetic compound targeting hepatic gluconeogenesis.
Area of Science:
- Pharmacology
- Biochemistry
- Hepatology
Background:
- Panax ginseng, a popular medicinal herb, exhibits antidiabetic properties.
- Ginsenosides are the primary compounds responsible for ginseng's antidiabetic effects.
- AMP-activated protein kinase (AMPK) is a key regulator of cellular energy metabolism.
Purpose of the Study:
- To investigate the effect of ginsenoside Rb2 on hepatic gluconeogenesis.
- To determine the role of AMPK in the antidiabetic activity of ginsenoside Rb2.
- To identify novel ginsenosides that can modulate glucose production.
Main Methods:
- In vitro study using H4IIE rat hepatocytes.
- Treatment with palmitate to induce gluconeogenesis.
- Analysis of AMPK activation and small heterodimer partner (SHP) expression.
Main Results:
- Ginsenoside Rb2 significantly inhibited palmitate-induced gluconeogenesis.
- Rb2 activated AMPK and upregulated SHP expression.
- Rb2 is the first protopanaxadiol-type ginsenoside demonstrated to inhibit hepatic gluconeogenesis via AMPK activation.
Conclusions:
- Ginsenoside Rb2 possesses antidiabetic potential by suppressing hepatic glucose production through the AMPK pathway.
- Further research is warranted to explore Rb2's efficacy in diabetic models and patients.
- This study expands the understanding of ginsenosides' mechanisms in glucose regulation.
Related Concept Videos
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...